ARIEL: A biomarker enrichment trial of anti-EGFR agents in patients with advanced colorectal cancer with wild-type RAS and right primary tumour location

Project Details

Short titleARIEL: A biomarker enrichment trial of anti-EGFR agents in patients with advanced colorectal cancer with wild-type RAS and right primary tumour location
StatusActive
Effective start/end date1/10/20 → 31/03/26

Funding

  • NIHR